Moderna Inc at Morgan Stanley Global Healthcare Conference Transcript
Good morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Really pleased to have Moderna with us. Quickly before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.
So really pleased to have Stephen Hoge, who is the President of Moderna with us.
Questions & Answers
Stephen, I thought a good place to start off is, before we go into details about the many programs that you have ongoing, everybody obviously knows the company because of COVID. And as I think about the stock, right, there's a decent amount of debate still on what the COVID tail looks like. But I think when you think about the company,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |